Literature DB >> 16417528

Chronic bilateral stimulation of the anterior thalamus of kainate-treated rats increases seizure frequency.

Fred A Lado1.   

Abstract

PURPOSE: Electrical stimulation of the anterior nucleus of the thalamus (ANT) is receiving increased attention as a novel means of controlling intractable epilepsy, and has entered human clinical trial. Animal data supporting the anticonvulsant benefit of ANT stimulation, however, has been obtained from acute chemoconvulsant models of epilepsy rather than models of chronic epilepsy with spontaneous seizures. It is unknown whether ANT stimulation is effective in models of chronic epilepsy.
METHODS: Bilateral ANT stimulation was evaluated in rats with chronic epilepsy following acute status epilepticus (SE) produced by systemic kainic acid (KA) administration. The evolution of epilepsy following KA SE and the effects of ANT stimulation were monitored by continuous video-EEG.
RESULTS: Following KA SE, most rats have 2-8 seizures per day, and the average seizure rate increases over time, doubling over the course of 14 weeks. Behavioral seizure severity, after the initial development of epilepsy, remains stable. Seizure frequency during ANT stimulation was 2.5 times the baseline seizure frequency. In some cases stimulation triggered seizures were observed. The effects of stimulation were specific to the ANT. Stimulation applied to electrodes placed outside the ANT did not significantly worsen seizure frequency.
CONCLUSIONS: ANT stimulation exacerbated seizure frequency in rats with chronic epilepsy following kainate status epilepticus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417528     DOI: 10.1111/j.1528-1167.2006.00366.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  15 in total

1.  Electrical stimulation in epilepsy: vagus nerve and brain stimulation.

Authors:  Barbara C Jobst
Journal:  Curr Treat Options Neurol       Date:  2010-09       Impact factor: 3.598

Review 2.  Animal models of temporal lobe epilepsy following systemic chemoconvulsant administration.

Authors:  Maxime Lévesque; Massimo Avoli; Christophe Bernard
Journal:  J Neurosci Methods       Date:  2015-03-10       Impact factor: 2.390

3.  Deep brain stimulation for epilepsy.

Authors:  Casey H Halpern; Uzma Samadani; Brian Litt; Jurg L Jaggi; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

Review 4.  How do seizures stop?

Authors:  Fred A Lado; Solomon L Moshé
Journal:  Epilepsia       Date:  2008-05-21       Impact factor: 5.864

5.  Should stimulation parameters be individualized to stop seizures: Evidence in support of this approach.

Authors:  Tiwalade Sobayo; David J Mogul
Journal:  Epilepsia       Date:  2015-12-09       Impact factor: 5.864

Review 6.  Electrical brain stimulation for epilepsy.

Authors:  Robert S Fisher; Ana Luisa Velasco
Journal:  Nat Rev Neurol       Date:  2014-04-08       Impact factor: 42.937

Review 7.  The kainic acid model of temporal lobe epilepsy.

Authors:  Maxime Lévesque; Massimo Avoli
Journal:  Neurosci Biobehav Rev       Date:  2013-10-30       Impact factor: 8.989

Review 8.  The anterior thalamus provides a subcortical circuit supporting memory and spatial navigation.

Authors:  Maciej M Jankowski; Kim C Ronnqvist; Marian Tsanov; Seralynne D Vann; Nicholas F Wright; Jonathan T Erichsen; John P Aggleton; Shane M O'Mara
Journal:  Front Syst Neurosci       Date:  2013-08-30

Review 9.  Mapping epileptic activity: sources or networks for the clinicians?

Authors:  Francesca Pittau; Pierre Mégevand; Laurent Sheybani; Eugenio Abela; Frédéric Grouiller; Laurent Spinelli; Christoph M Michel; Margitta Seeck; Serge Vulliemoz
Journal:  Front Neurol       Date:  2014-11-05       Impact factor: 4.003

10.  Effects of anterior thalamic nucleus deep brain stimulation in chronic epileptic rats.

Authors:  Luciene Covolan; Antônio-Carlos G de Almeida; Beatriz Amorim; Clarissa Cavarsan; Maisa Ferreira Miranda; Mayra C Aarão; Ana Paula Madureira; Antônio M Rodrigues; José N Nobrega; Luiz E Mello; Clement Hamani
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.